Pharmacyclics, Inc. (NASDAQ:PCYC)

ASCO 2013 provides upside potential !

This pick was made because its below the 50day moving average as of April 10th.
The whole list I perused through below 50dmva for 4/10/13 were;
AMZN,SIRI,PRAN,PCYC,CNQR,PCLN,CRM,LULU,CVLT,NFLX,ULTI,CTXS

These tickers were picked from my tracking universe of the following tickers:
CCI,AMZN,SIRI,LMT,PNRA,SBAC,RPRX,PRAN,MDVN,VZ,ALXN,PCYC,CNQR,INFI,VRTX,PCLN,CRM,LULU,CVLT,NFLX,OPEN,GMCR,N,CAR,REGN,T,SBUX,MO,ULTI,MAR,EQIX,CTXS,CLH,BLL

This was supposed to be a simple tracking blog post rather than a pitch but as a new player, it takes a couple of days to be approved for blog posting...oh well. Hopefully I remember to look back at these pitches.

Great company with lots of cash that has been shooting up for a long time. I bought on the dip today and I'm buying in my motley fool caps as well.

They're finally profitable and they got profitable in a big way.

Price levels are out of whack with fundamentals

outperform

Game changing medication for several forms of leukemia, including CLL, about to be approved by FDA.

http://caps.fool.com/Blogs/fund-trades/779590.
http://twitter.com/portefeuillefun.

1 star caps rating? another reason why we should not rely on the so called TMF pros. Good lesson of humility for some of them.

Immunokinases are a hot target these days, as hot as the multibillion market opportunity of hematological cancers. Of course, any safety/efficacy issues and the stock will tank hard

Parabolic technicals, stupidly overvalued fundamentals

Why is this stock valued as if all of the company's drugs have been approved? Ridiculous valuation for an early stage biotech!

Eegads... don't think I've ever seen so many highly-ranked fools with -1000+ points associated as with this stock. Maybe shipping or solar, back in the day. Anyway, underperform...

one anomolous quarter is pumping up their earnings and stock price. None of their drugs have even started stage 3 trials yet. Stock spammers love them.

Ibrutinib has potential, but risk reward is too unfavorable after the run up.

went to 300% increase for potofeille.

high relative strenght

I think pcyc will hit $50.00 in 5years.

What happens to a shooting star when it has no FDA approvals on products. It will need more cash to burn...

Skyrocketed based on expectations; no tangible results & more lofty expectations based on today's valuation compared to most other biotechs